Hospitalizations for heart failure on the decline; disparities remain for blacks and men

June 27, 2017

DALLAS, June 27, 2017 - The number of people hospitalized for heart failure in the United States declined about 30 percent between 2002 and 2013, but large disparities between blacks vs. whites and men vs. women remain, according to new research in Circulation: Cardiovascular Quality and Outcomes, an American Heart Association journal.

The study is the first to report on the age-standardized racial/ethnic differences in national heart failure hospitalization rates between whites, blacks, Hispanics and Asians/Pacific Islanders.

Researchers examined data from the National Inpatient Survey from 2002-2013, which consisted of data from 7-8 million hospital discharge per year across thousands of hospitals.

They found: The decrease in hospitalization rates suggest that efforts to improve outpatient treatment and prevention measures have successfully reduced the number of heart failure patients needing hospitalization. However, the improvements are not equally distributed across races/ethnicities and genders.

"Disparities in disease burden for males and especially African-Americans have not improved in the recent decade," said lead author Boback Ziaeian, M.D., Ph.D., clinical instructor at the University of California Los Angeles and the U.S. Department of Veterans Affairs. "The findings highlight the need to address population-based health, prevention and outpatient management of chronic diseases."

The authors note higher hospitalization burden among blacks and Hispanics is more reflective of underlying social determinants of health of health rather than genetics or physiologic differences.

The results should be met with caution as data collection had limitations.
-end-
Co-authors are Gerald F. Kominski, Ph.D., Michael K. Ong, M.D., Ph.D.., Vickie M.

Mays, Ph.D., Robert H. Brook, M.D., Sc.D. and Gregg C. Fonarow, M.D. Author disclosures are on the manuscript.

The National Institutes of Health partially funded the study.

Additional Resources:

After June 27, view the manuscript online.

Visit AHA's Heart Failure Website

Follow AHA/ASA news on Twitter @HeartNews

Follow CircCVQO on Twitter: Circulation: CVQO@CircOutcomes

Statements and conclusions of study authors published in American Heart Association scientific journals are solely those of the study authors and do not necessarily reflect the association's policy or position. The association makes no representation or guarantee as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations and health insurance providers are available at http://www.heart.org/corporatefunding.

About the American Heart Association

The American Heart Association is devoted to saving people from heart disease and stroke - the two leading causes of death in the world. We team with millions of volunteers to fund innovative research, fight for stronger public health policies, and provide lifesaving tools and information to prevent and treat these diseases. The Dallas-based association is the nation's oldest and largest voluntary organization dedicated to fighting heart disease and stroke. To learn more or to get involved, call 1-800-AHA-USA1, visit heart.org or call any of our offices around the country. Follow us on Facebook and Twitter.

American Heart Association

Related Heart Failure Articles from Brightsurf:

Top Science Tip Sheet on heart failure, heart muscle cells, heart attack and atrial fibrillation results
Newly discovered pathway may have potential for treating heart failure - New research model helps predict heart muscle cells' impact on heart function after injury - New mass spectrometry approach generates libraries of glycans in human heart tissue - Understanding heart damage after heart attack and treatment may provide clues for prevention - Understanding atrial fibrillation's effects on heart cells may help find treatments - New research may lead to therapy for heart failure caused by ICI cancer medication

Machining the heart: New predictor for helping to beat chronic heart failure
Researchers from Kanazawa University have used machine learning to predict which classes of chronic heart failure patients are most likely to experience heart failure death, and which are most likely to develop an arrhythmic death or sudden cardiac death.

Heart attacks, heart failure, stroke: COVID-19's dangerous cardiovascular complications
A new guide from emergency medicine doctors details the potentially deadly cardiovascular complications COVID-19 can cause.

Autoimmunity-associated heart dilation tied to heart-failure risk in type 1 diabetes
In people with type 1 diabetes without known cardiovascular disease, the presence of autoantibodies against heart muscle proteins was associated with cardiac magnetic resonance (CMR) imaging evidence of increased volume of the left ventricle (the heart's main pumping chamber), increased muscle mass, and reduced pumping function (ejection fraction), features that are associated with higher risk of failure in the general population

Transcendental Meditation prevents abnormal enlargement of the heart, reduces chronic heart failure
A randomized controlled study recently published in the Hypertension issue of Ethnicity & Disease found the Transcendental Meditation (TM) technique helps prevent abnormal enlargement of the heart compared to health education (HE) controls.

Beta blocker use identified as hospitalization risk factor in 'stiff heart' heart failure
A new study links the use of beta-blockers to heart failure hospitalizations among those with the common 'stiff heart' heart failure subtype.

Type 2 diabetes may affect heart structure and increase complications and death among heart failure patients of Asian ethnicity
The combination of heart failure and Type 2 diabetes can lead to structural changes in the heart, poorer quality of life and increased risk of death, according to a multi-country study in Asia.

Preventive drug therapy may increase right-sided heart failure risk in patients who receive heart devices
Patients treated preemptively with drugs to reduce the risk of right-sided heart failure after heart device implantation may experience the opposite effect and develop heart failure and post-operative bleeding more often than patients not receiving the drugs.

How the enzyme lipoxygenase drives heart failure after heart attacks
Heart failure after a heart attack is a global epidemic leading to heart failure pathology.

Novel heart pump shows superior outcomes in advanced heart failure
Severely ill patients with advanced heart failure who received a novel heart pump -- the HeartMate 3 left ventricular assist device (LVAD) -- suffered significantly fewer strokes, pump-related blood clots and bleeding episodes after two years, compared with similar patients who received an older, more established pump, according to research presented at the American College of Cardiology's 68th Annual Scientific Session.

Read More: Heart Failure News and Heart Failure Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.